Trial Profile
Strategies for Enhancing Mucosal Immunity to Influenza Vaccine.
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 01 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2011 New trial record